Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress

Arcturus Therapeutics (ARCT) Tops Q4 EPS by 63c

March 7, 2024 4:04 PM EST

Arcturus Therapeutics (NASDAQ: ARCT) reported Q4 EPS of ($0.32), $0.63 better than the analyst estimate of ($0.95). Revenue for the quarter came in at $33.99 million versus the consensus estimate of $42.54 million.

For earnings history and earnings-related data on Arcturus Therapeutics (ARCT) click here.

... More